is golo a glp 1 Weight Loss Program | GOLO For Life Recipes GOLO Weight Loss Program |
Description
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index

These blockbuster therapies are clear indicators of where innovation and market momentum are heading in 2025

High protein, nausea-friendly, and perfect for quieting food noise

Former seven-time Mr